Taurine

牛磺酸

Report date: 2026/05/07 20:00:36

Base Information

Drug NameTaurine
Drug Alias Name2-Aminoethanesulfonic acid氨基乙磺酸Taurine
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsIschemic StrokePost-Acute COVID-19 SyndromeParenteral Nutrition +[15
Global Approved IndicationsFeverHyperbilirubinemiaHeart Failure +[4
Approved Indications in ChinaFever
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesAustralia +[7
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active IndicationsIschemic StrokePost-Acute COVID-19 SyndromeParenteral Nutrition +[11
Inactive IndicationsPsychotic DisordersBipolar DisorderCardiomyopathies +[4

Other Information

ATC CodeB05BAV06D